Allspring Global Investments Holdings, LLC Voyager Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $54.8 Billion
- Q2 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 56,910 shares of VYGR stock, worth $192,924. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,910
Previous 60,462
5.87%
Holding current value
$192,924
Previous $204,000
13.73%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VYGR
# of Institutions
118Shares Held
32.4MCall Options Held
32.9KPut Options Held
22.7K-
Black Rock Inc. New York, NY5.31MShares$18 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.8MShares$16.3 Million0.26% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$13.3 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.9 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$5 Million0.24% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $131M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...